Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Colorectal carcinogenesis progression
- Breast cancer xenograft in a mouse host
- Epithelial vs. mesenchymal state & adjacent stroma
- The epithelial-mesenchymal transition
- EMT in sea urchin embryo
- EMT-TFs at various stages of embryogenesis
- EMT is a confluence of contextual signals
- Heterotypic signals that provoke an EMT
- Heterotypic interaction schematic
- Signaling leading to NF-kB activation
- Sub populations of breast cancer cells
- Stem cell (SC) scheme
- EMT by Snail & Twist generates stem-like cells
- CD44hi/CD24lo epithelial cells
- EMT and cancer progression
- In vivo mammary stem cell assay
- Mouse stem cells show mesenchymal attributes
- Slug and mammary gland-reconstituting activity
- Transient expression of two EMT-inducing TFs
- Primary tumor cells genetics
- Control tumor versus EMTed tumor
- EMTed tumors display stroma-rich phenotype
- Slug and SOX9 increase metastatic ability of cells
- Epigenetic signals activate EMT
- EMT-inducing TFs in normal mammary epithelium
- The mammary epithelium as a model system
- Transgenic model of breast cancer pathogenesis
- Differential expression of Snail and Slug
- Process of carcinoma progression using model
- Location of Slug in normal cell & early stage tumor
- Snail expression leads to loss of E-Cadherin
- Snail activation as tumors progress
- Snail expressing cells lead invasion in culture
- Proposed model: distinct EMT programs
- Tumor initiation ability
- Snail(hi) vs. Slug(hi) cells
- Proposed model of EMT-TF activation: summary
- Protein domain comparisons of Snail and Slug
- ChIP-seq of Slug and Snail binding targets
Topics Covered
- Understanding carcinoma invasion and metastasis
- Epithelial-mesenchymal transition (EMT)
- Heterotypic signals in tumor growth and progression
- EMT-inducing transcription factors
- Transgenic model of breast cancer pathogenesis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Weinberg, R. (2024, October 6). Genetics of tumor metastasis 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/RRCF6999.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert Weinberg has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Genetics of tumor metastasis 1
Other Talks in the Series: Cancer Genetics
Transcript
Please wait while the transcript is being prepared...
0:00
Good morning.
Robert Weinberg calling in here
from the Whitehead Institute
for Biomedical Research
in the MIT Department
of Biology,
both in Cambridge,
Massachusetts, USA.
My talk today will be
on the mechanisms of metastasis,
focusing ostensibly
on the genetics of metastasis,
but in fact there will be
great emphasis
on the non-genetic mechanisms
of metastasis, that is,
changes in epigenetics,
the control
of gene transcription
and how that effects
the biology of cancer cells
that are in the course
of metastasizing.
0:36
In the first slide here,
we see a description
of how colorectal carcinogenesis
proceeds as first enunciated,
described
by Kinsler and Vogelstein
in 1989.
And what we see here
is that when one moves
progressively
from a normal colonic
epithelial tissue
towards a primary tumor,
which in this case
is labeled a carcinoma,
one sees
a series of intermediate steps
which involve the accumulation
of distinct genetic alterations
including the loss of APC,
chromosome 18 associated
to tumor suppressor gene,
the loss of P53,
and the activation
of the K-ras oncogene.
And together,
these operate in concert
to create a primary tumor.
The question is, however,
what happens subsequently
when the carcinoma
depicted on the slide
to the right actually begins
to disseminate,
that is send cells
to distant tissues
in the case of colon cancer,
for example, into the liver.
The question of
what goes on here
is critically important
because of the important role
of metastases
in generating a large proportion
of cancer
associated mortality.